INKT: MiNK Therapeutics, Inc. Stock

by  •  • Comments Off on INKT: MiNK Therapeutics, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 30.94
Enterprise Value ($M) 31.29
Book Value ($M) -19.59
Book Value / Share -4.94
Price / Book -1.58
NCAV ($M) -20.32
NCAV / Share -5.12
Price / NCAV -1.52

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -1.56
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.72
Current Ratio 0.72

Balance Sheet (mrq) ($M)
Current Assets 4.99
Assets 5.72
Liabilities 25.31
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -11.29
Net Income -10.78
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -9.56
Cash from Investing 0.00
Cash from Financing 10.82

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
05-22 13G Gkcc, Llc 11.79

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-18 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 1,077 2,247 47.93
2025-04-16 869 2,763 31.45
2025-04-15 405 1,571 25.78
2025-04-14 1,014 3,298 30.75

(click for more detail)

Similar Companies
IMTX – Immatics N.V. INAB – IN8bio, Inc.
INDP – Indaptus Therapeutics, Inc. INM – InMed Pharmaceuticals Inc.
INMB – INmune Bio, Inc.


Financial data and stock pages provided by
Fintel.io